19 June 2013
Keywords: ucb, submits, pediatric, iv, keppra, filings, pharma
Article | 10 January 2005
UCB Pharma has filed a supplemental New Drug Application with the US Food and Drug Administration for a pediatric indication ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 January 2005
13 December 2004
18 June 2013
© 2013 thepharmaletter.com